IBAB Ion Beam Applications SA

IBA to share long-term growth strategy at upcoming 2025 Capital Markets Day

IBA to share long-term growth strategy at upcoming 2025 Capital Markets Day



Louvain-la-Neuve, Belgium, 04 April, 2025 –  (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, will be hosting a Capital Markets Day (CMD) this coming Monday 7 April from 2pm to 5:00pm CEST (8am ET to 11:00am ET) at its headquarters in Louvain-la-Neuve, Belgium, and via live webcast.

At the event IBA’s management team will outline the company’s strategic roadmap and long-term growth ambitions. The agenda is outlined below:

  • Webcast open: 2pm
  • Purpose, Vision & Strategy​​
  • Business Review – Execution Plan & Opportunities​​
    • Industrial Solutions
    • RadioPharma Solutions
    • Engineering & Supply Chain
    • Proton Therapy
    • Dosimetry
    • New Ventures
  • Financials & Outlook
  • Webcast close: 5pm

To attend via webcast, register via this . Please complete the registration at least 15 minutes before the start of the event. No new material financial information will be delivered during the CMD.

The presentation will be made available on IBA’s website ahead of the event on and a recording will also be made available shortly afterwards on the same page and on .

For further information, please contact ICR Healthcare at .   

***ENDS***

About IBA

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the fields of proton therapy, considered as the most advanced form of radiation therapy available today, as well as industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,100 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

More information can be found at:

CONTACTS

Olivier Lechien

Corporate Communication Director



ICR Healthcare

Amber Fennell, Angela Gray, Lucy Featherstone

+44 (0) 20 3709 5700

Attachment



EN
04/04/2025

Underlying

IBABIon Beam Applications SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ion Beam Applications SA

Guy Sips ... (+5)
  • Guy Sips
  • Jacob Mekhael
  • Kristof Samoy
  • Michiel Declercq
  • Wim Lewi
EXM EXMAR N.V.
XIOR XIOR STUDENT HOUSING N.V.
IBAB ION BEAM APPLICATIONS SA
GLPG GALAPAGOS NV
BAR BARCO NV
FUR FUGRO NV
DEME DEME GROUP NV
04/22/25 April 22, 2025 1 EN
Michiel Declercq
  • Michiel Declercq
IBAB Ion Beam Applic...

IBA Ambitious plans, but short-term profitability in focus

Following the CMD on April 4th and new reporting structure from 2025 onwards, we have revisited our estimates accordingly. Overall, we believe IBA left a good impression during the CMD. While the numerous new initiatives and growth areas might look overwhelming, we believe they reconfirm the potential of IBA's technology. More importantly, the PanTera deal already showcased that new opportunities can create significant value with limited upfront investments. While the impact from tariffs on shor...

IBAB ION BEAM APPLICATIONS SA
04/22/25 April 22, 2025 1 EN
 PRESS RELEASE
Free
IBAB Ion Beam Applic...

IBA – ACQUISITION OF OWN SHARES

IBA – ACQUISITION OF OWN SHARES Immediate Release – April 18th, 2025 Louvain-la-Neuve, Belgium, April 18th, 2025 - In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on March 24th, 2025. Under this program, IBA has requested a financial intermediary to repurchase up to 650,000 IBA ordinary shares on its behalf under the terms of a mandate with validity until December 31st, 2025, effective as from Marc...

April 18, 2025 1 EN
 PRESS RELEASE
Free
IBAB Ion Beam Applic...

IBA – ACQUISITION D’ACTIONS PROPRES

IBA – ACQUISITION D’ACTIONS PROPRES Publication immédiate – 18 avril 2025 Louvain-la-Neuve, Belgique, 18 avril 2025 - Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") communique par la présente certaines informations relatives à son programme de rachat d'actions annoncé le 24 mars 2025. Dans le cadre de ce programme, IBA a demandé à un intermédiaire financier de racheter en son nom un maximum de 650.000 actions ordinaires IBA selon les termes d'un mandat valable jusqu'au 31 dé...

April 18, 2025 1 EN
 PRESS RELEASE
Free
IBAB Ion Beam Applic...

IBA – ACQUISITION OF OWN SHARES

IBA – ACQUISITION OF OWN SHARES Immediate Release – April 14th, 2025 Louvain-la-Neuve, Belgium, April 14th, 2025 - In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on March 24th, 2025. Under this program, IBA has requested a financial intermediary to repurchase up to 650,000 IBA ordinary shares on its behalf under the terms of a mandate with validity until December 31st, 2025, effective as from Marc...

April 14, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch